- Patent Title: Use of DDX3X inhibitors for the treatment of pneumovirus infections
-
Application No.: US15124748Application Date: 2015-03-12
-
Publication No.: US09884812B2Publication Date: 2018-02-06
- Inventor: Andrew Easton , Phillip Gould , Andrew Marsh
- Applicant: UNIVERSITY OF WARWICK
- Applicant Address: GB
- Assignee: UNIVERSITY OF WARWICK
- Current Assignee: UNIVERSITY OF WARWICK
- Current Assignee Address: GB
- Agency: Sheridan Ross P.C.
- Priority: GB1404372.3 20140312
- International Application: PCT/GB2015/050724 WO 20150312
- International Announcement: WO2015/136292 WO 20150917
- Main IPC: A61K31/535
- IPC: A61K31/535 ; C07C275/30 ; C07C275/42 ; C07C275/40 ; C07C323/44 ; C07D213/75 ; C07C317/42 ; C07D239/42 ; C07D295/16 ; G01N33/573 ; G01N33/53 ; A61K31/5375
Abstract:
The invention relates to a DDX3X inhibitor for use in the treatment of pneumovirus infection in a mammal, wherein the DDX3X inhibitor may be a compound of Formula (I) wherein y, Z, R1, X, L, Ra and Rb are as defined herein. The invention also relates to compounds of Formula (I).
Public/Granted literature
- US20170166519A1 USE OF DDX3X INHIBITORS FOR THE TREATMENT OF PNEUMOVIRUS INFECTIONS Public/Granted day:2017-06-15
Information query
